Yesterday, Nov. 18, 2015, 127 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $235.29 to $228,091,773.00.

Highlighted Stocks Traded by Insiders:

Zimmer Biomet Holdings (ZBH) - FREE Research Report

Nolan David A. Jr., who is Group President at Zimmer Biomet Holdings, sold 742 shares at $104.85 on Nov. 18, 2015. Following this transaction, the Group President owned 12,139 shares meaning that the stake was reduced by 5.76% with the 742-share transaction.

The shares most recently traded at $104.21, down $0.64, or 0.61% since the insider transaction. Historical insider transactions for Zimmer Biomet Holdings go as follows:

  • 4-Week # shares bought: 1,900
  • 4-Week # shares sold: 69,600
  • 12-Week # shares bought: 1,900
  • 12-Week # shares sold: 69,600
  • 24-Week # shares bought: 1,900
  • 24-Week # shares sold: 69,600

The average volume for Zimmer Biomet Holdings has been 1.4 million shares per day over the past 30 days. Zimmer Biomet Holdings has a market cap of $21.3 billion and is part of the health care sector and health services industry. Shares are down 7.45% year-to-date as of the close of trading on Wednesday.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, develops, manufactures, and markets orthopaedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. The stock currently has a dividend yield of 0.84%. The company has a P/E ratio of 104.8. Currently, there are 16 analysts who rate Zimmer Biomet Holdings a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ZBH - FREE

TheStreet Quant Ratings

rates Zimmer Biomet Holdings as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full

Zimmer Biomet Holdings Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

BankUnited (BKU) - FREE Research Report

DeMark Eugene F, who is Director at BankUnited, sold 5,000 shares at $37.81 on Nov. 18, 2015. Following this transaction, the Director owned 18,682 shares meaning that the stake was reduced by 21.11% with the 5,000-share transaction.

The shares most recently traded at $37.87, up $0.06, or 0.15% since the insider transaction. Historical insider transactions for BankUnited go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 1,000
  • 24-Week # shares bought: 1,900
  • 24-Week # shares sold: 11,000

The average volume for BankUnited has been 759,900 shares per day over the past 30 days. BankUnited has a market cap of $3.9 billion and is part of the financial sector and banking industry. Shares are up 31.2% year-to-date as of the close of trading on Wednesday.

BankUnited, Inc. operates as the bank holding company for BankUnited, National Association that provides a range of banking products services to commercial and middle-market businesses, and individual customers in the United States. The stock currently has a dividend yield of 2.24%. The company has a P/E ratio of 16.5. Currently, there are 5 analysts who rate BankUnited a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BKU - FREE

TheStreet Quant Ratings

rates BankUnited as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, good cash flow from operations, expanding profit margins and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

BankUnited Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Scientific Games (SGMS) - FREE Research Report

Isaacs Michael Gavin, who is President and CEO at Scientific Games, bought 30,000 shares at $7.96 on Nov. 18, 2015. Following this transaction, the President and CEO owned 44,754 shares meaning that the stake was boosted by 203.33% with the 30,000-share transaction.

The shares most recently traded at $8.70, up $0.74, or 8.51% since the insider transaction. Historical insider transactions for Scientific Games go as follows:

  • 4-Week # shares bought: 42,675
  • 4-Week # shares sold: 13,790
  • 12-Week # shares bought: 42,675
  • 12-Week # shares sold: 13,790
  • 24-Week # shares bought: 42,675
  • 24-Week # shares sold: 13,790

The average volume for Scientific Games has been 1.1 million shares per day over the past 30 days. Scientific Games has a market cap of $701.9 million and is part of the services sector and leisure industry. Shares are down 38.81% year-to-date as of the close of trading on Wednesday.

Scientific Games Corporation develops technology-based products and services, and associated content for the gaming and lottery industries worldwide. The company operates through three segments: Gaming, Lottery, and Interactive. Currently, there are 5 analysts who rate Scientific Games a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SGMS - FREE

TheStreet Quant Ratings

rates Scientific Games as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and generally disappointing historical performance in the stock itself. Get the full

Scientific Games Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.